v3.25.4
Segment Information
 9 Months Ended
Dec. 28, 2025
Segment Reporting [Abstract]  
Segment Information Segment Information
Effective beginning with the first fiscal quarter of fiscal 2026, we realigned our reporting segments to reflect organizational changes made and to reflect the way we manage our operations and allocate resources. We believe this realignment better reflects the value our company provides to our customers and our evolution from a bulk commodity distributor into a specialty ingredients company. In fiscal 2026, we organize and manage our business by the following three segments, each of which meets the definition of reportable segments under ASC 280-10, Segment Reporting: Water Treatment, Food & Health Sciences, and Industrial Solutions. These segments are defined primarily by product and type of customer.
Our chief operating decision-maker (CODM), who is our President and Chief Executive Officer, regularly reviews the consolidated financial statements in their entirety and financial information at the reportable segment level. The CODM uses operating income and considers budget-to-actual variances on a quarterly basis when making decisions about the allocation of operating and capital resources to each segment. The CODM also uses segment operating income for evaluating pricing strategy, to assess the performance of each segment by comparing the results of each segment with one another, and in determining the compensation of certain employees. The CODM has ultimate responsibility for enterprise decisions and making resource allocation decisions for the Company and the segments.
•Our Water Treatment segment specializes in providing chemicals, products, equipment, services and solutions for potable water, municipal and industrial wastewater, industrial process water, non-residential swimming pool water and agricultural water. This segment has the resources and flexibility to treat systems ranging in size from a single small well to a multi-million-gallon-per-day facility.
•Our Food & Health Sciences segment specializes in processing and formulation solutions as well as ingredient distribution to manufacturers in the nutrition, food, pharmaceutical, and agricultural markets. This segment offers a diverse product portfolio including base chemistry, acid based reactions, minerals, vitamins and amino acids, excipients, botanicals and herbs, sweeteners and enzymes, fertilizers, and food-grade and pharmaceutical salts and ingredients.
•Our Industrial Solutions segment specializes in providing industrial chemicals, products and services to industries such as industrial manufacturing, chemical processing, electronics, energy, plating, and surface finishing. This segment’s principal products are acids and alkalis.
The accounting policies of the segments are the same as those described in the summary of significant accounting policies. Product costs and expenses for each segment are based on actual costs incurred along with cost allocations of shared and centralized functions.
There are no intersegment sales and no operating segments have been aggregated.
In fiscal 2026 and 2025, none of our customers accounted for 10% or more of our total sales.
Summarized financial information for our reportable segments is presented and reconciled to consolidated financial information in the following tables:
(In thousands)Water
Treatment		Food & Health SciencesIndustrial SolutionsTotal
Three months ended December 28, 2025:
Sales$120,487 $70,004 $53,589 $244,080 
Cost of sales - materials(73,957)(50,710)(42,529)(167,196)
Cost of sales - operational overhead(16,976)(5,447)(3,648)(26,071)
Gross profit29,554 13,847 7,412 50,813 
Selling, general, and administrative expenses(16,715)(8,166)(3,376)(28,257)
Operating income12,839 5,681 4,036 22,556 
Interest expense, net(3,434)
Other income459 
Income tax expense(5,269)
Net income14,312 
Identifiable assets*564,689 244,038 132,946 941,673 
Capital expenditures8,021 2,941 3,359 14,321 
Depreciation and amortization7,902 3,290 2,218 13,410 
(In thousands)Water
Treatment		Food & Health SciencesIndustrial SolutionsTotal
Three months ended December 29, 2024:
Sales$99,752 $77,730 $48,723 $226,205 
Cost of sales - materials(58,546)(55,944)(38,075)(152,565)
Cost of sales - operational overhead(15,350)(5,497)(4,369)(25,216)
Gross profit25,856 16,289 6,279 48,424 
Selling, general, and administrative expenses(16,058)(7,761)(3,542)(27,361)
Operating income9,798 8,528 2,737 21,063 
Interest expense, net(1,216)
Other income436 
Income tax expense(5,262)
Net income15,021 
Identifiable assets*124,713 306,859 242,334 673,906 
Capital expenditures4,361 2,113 2,248 8,722 
Depreciation and amortization4,808 3,151 2,152 10,111 
Nine months ended December 28, 2025:
Sales$420,961 $232,095 $164,730 $817,786 
Cost of sales - materials(251,930)(169,677)(130,508)(552,115)
Cost of sales - operational overhead(52,469)(13,742)(8,642)(74,853)
Gross profit116,562 48,676 25,580 190,818 
Selling, general, and administrative expenses(57,871)(24,631)(10,487)(92,989)
Operating income58,691 24,045 15,093 97,829 
Interest expense, net(10,535)
Other income2,122 
Income tax expense(23,331)
Net income66,085 
Capital expenditures22,614 7,728 8,321 38,663 
Depreciation and amortization22,660 9,704 6,599 38,963 
Nine months ended December 29, 2024:
Sales$341,456 $234,225 $153,432 $729,113 
Cost of sales - materials(195,807)(168,545)(120,321)(484,673)
Cost of sales - operational overhead(48,657)(13,423)(9,059)(71,139)
Gross profit96,992 52,257 24,052 173,301 
Selling, general, and administrative expenses(45,962)(22,582)(10,158)(78,702)
Operating income51,030 29,675 13,894 94,599 
Interest expense, net(3,906)
Other income1,268 
Income tax expense(23,943)
Net income68,018 
Capital expenditures15,910 6,695 7,403 30,008 
Depreciation and amortization13,673 9,362 6,333 29,368 
*Unallocated assets not included, consisting primarily of cash and cash equivalents, prepaid expenses, and non-qualified deferred compensation plan assets of $34.9 million at December 28, 2025 and $33.3 million at December 29, 2024.